1. Home

Drugs

The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United States

Topic Paragraphs
Digital Illustration of circuitry with floating panels containing code

FDA launches new adverse event look-up tool

As part of a commitment to modernization and transparency, the agency is offering direct access to product safety data. All submitted reports are now consolidated into one streamlined, user-friendly dashboard for scientists, researchers, and the public.

Learn more
Consumer Contact Information Drug Alerts and Statements What's New Related to Drugs

Search our databases:

Drugs@FDA

Find information about most FDA-approved prescription, generic, and over-the-counter drug products.

Drug Shortages

Find information about drug shortages caused by manufacturing and quality problems, delays, and discontinuations.

Orange Book

The Orange Book identifies drug products approved by FDA on the basis of safety and effectiveness.

News

A man in a blue shirt with his eyes closed, leaning forward and pinching the bridge of his nose as if in pain or from stress.

Call-to-action encourages new uses for testosterone replacement therapy

Agency promotes exploring low libido treatments for men with hypogonadism
A decorative image with a blue border and the words 'DRUG APPROVAL: New Indication' in dark blue text. Red and white capsules and clear bubbles float in the background.

New treatment targets rare kidney disease for the first time

Therapy now includes children eight and older with FSGS without nephrotic syndrome
A photo collage displaying seven different bottles and boxes of dietary supplements labeled in Spanish. The products shown include Kuka Flex CBD, Curcuflex, Umary, Yeicob, and RM Joe.
Pictured are some of the hyaluronic acid products found to contain hidden drug ingredients. Using these unapproved products can lead to severe health issues and hospitalization.

Hidden ingredients pose risks in some hyaluronic acid products

Using the unapproved products can lead to severe health issues and hospitalization

Navigate the Drugs Section

Center

Upcoming Drug-related Events

Priority Areas & Initiatives

Opioids

Reducing the impact of opioid misuse and abuse

Generics

Ensuring access to safe, affordable, and effective generic drugs

Warning Letters

Warning and Notice of Violation Letters to Pharmaceutical Companies

Guidances

FDA's current thinking on drug development and review activities

Drug Shortages

Search the database, learn about root causes and potential solutions

Resources

Information for consumers, health professionals, and industry

Contact Us

Division of Drug Information
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Building 51, Room 1109
Silver Spring, MD 20993

druginfo@fda.hhs.gov

Toll Free
(855) 543-3784
(301) 796-3400

Hours Available

Center for Drug Evaluation and Research (CDER)

Paragraph Header (Column 2)
FOR UPDATES ON X FOLLOW

@FDA_Drug_Info

Your source for the latest drug information.
Know the moment it happens.

Back to Top